Lung Cancer Clinical Trials

Showing 1461-1480 of 3,692 trials

Patient-derived Organoids of Lung Cancer to Test Drug Response

NCT03979170

This is a single center, single arm, open and exploratory clinical study, with 50 cases planned for a period of 3 years. The purpose of this study is to evaluate the consistency and accuracy of a Patient-Derived Organoid (PDO) Model of lung cancer to predict the clinical efficacy of anti-cancer drugs, in order to predict the best chemotherapy regimen for each given patient.

Lung CancerOrganoid

University Hospital, Geneva50 participantsStarted Apr 2019

Geneva, Switzerland

RECRUITINGEARLY Phase 1

An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer

NCT06436885

This is a single-arm, open, multicenter exploratory clinical trial to observe and evaluate the efficacy and safety of Iruplinalkib Tablets in patients with ROS1 positive non-small cell lung cancer.

Non-Small Cell Lung Cancer

Henan Cancer Hospital39 participantsStarted Feb 2024

Zhengzhou, Henan, China

Not Yet RecruitingPhase 2

A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC

NCT06434740

This study aims to evaluate the efficacy and safety of SBRT combined with Puterizumab immunotherapy for non-small cell lung cancer with pulmonary metastases, and to determine the correlation between MRD and treatment efficacy. Through single-cell sequencing and spatial transcriptome information analysis, the underlying mechanisms will be analyzed to provide a basis for improving the new precision treatment methods for tumor immunotherapy resistance.

Non-Small-Cell Lung Cancer

Sir Run Run Shaw Hospital37 participantsStarted Jun 2024

Patient-derived Organoids of Lung Cancer to Test Drug Response

An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer

A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC

Related Searches

Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLC

The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC

Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC

JDQ443 for KRAS G12C NSCLC Brain Metastases

Pulmonary sarcomatoid_MEDI4736+Treme

a Single-arm, Single-center, Open Clinical Study

Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen

A Prospective Interventional Study on Early Screening for Lung Cancer Using Liquid Biopsy

A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC

An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC

Efficacy Study of a Selective Chest Wall Restriction Belt in Postoperative of Lung Resection

Effects of Prehabilitation on Postoperative Recovery

Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer

A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients

Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness

A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis